Fakultní nemocnice Brno je zdravotnické zařízení v Brně, sídlící ve čtvrti Bohunice. FN Brno je komplex skládající se z několika pracovišť, která dohromady zajišťují zdravotní péči pro obyvatele Brna a Jihomoravského kraje a pro pacienty z části krajů Vysočina, Zlínského a Olomouckého.

During the past decade, University Hospital Brno conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 30 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 19 clinical trials were completed. i.e. 32.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Brno" #1 sponsor was "Brno University Hospital" with 51 trials, followed by "Boehringer Ingelheim" with 13 trials sponsored, "Czech Lymphoma Study Group" with 4 trials sponsored, "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Brno" #1 collaborator was "Masaryk University" with 15 trials as a collaborator, "Brno University Hospital" with 10 trials as a collaborator, "University Hospital Olomouc" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "St. Anne's University Hospital Brno, Czech Republic" with 3 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Brno" are "Coronary Artery Disease" (3 trials), "Lymphoma" (3 trials), "Multiple Sclerosis" (3 trials), "Muscular Dystrophy, Duchenne" (3 trials) and "Obstetric Anesthesia Care" (3 trials). Many other conditions were trialed in "University Hospital Brno" in a lesser frequency.

Most popular intervention types in "University Hospital Brno" are "Drug" (77 trials), "Other" (25 trials), "Device" (20 trials), "Procedure" (13 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Rituximab" (5 trials), "Dexamethasone" (4 trials), "Cyclophosphamide" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Brno" are 139 trials for "All" genders, 13 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 58 active trials in "University Hospital Brno". 6 are not yet recruiting, 39 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 77 completed trials in University Hospital Brno, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Brno, 10 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 29 trials that are defined as “Not Applicable".